Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México

Detalhes bibliográficos
Autor(a) principal: Molina-Salazar, Raúl E.
Data de Publicação: 1998
Outros Autores: Rivas-Vilchis, José F.
Tipo de documento: Artigo
Idioma: spa
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996
Resumo: Accessibility and availability of drugs has been a matter of great concern for health services all over the world, especially for less developed countries. The World Health Organization has devoted considerable time to this matter. Although the essential drug policy has been well-accepted by health agencies and NGOs, the pharmaceutical industry has not proven willing to produce essential drugs at affordable prices. The purpose of this study is to examine price levels of essential drugs in Mexico. The evaluation was performed through a comparison of international and national prices for leading drugs in the respective therapeutic categories and included in the WHO model list of essential drugs. The study shows clearly that prices of essential brand-name drugs in Mexico are very high. Per capita consumption has remained stable despite a sharp decrease in the Mexican GDP since 1995. The article discusses the reasons for this and proposes measures to deal with the problem.
id FIOCRUZ-5_3d86de7826e94d2b6d6bb99524d12432
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/996
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en MéxicoMedicamentos EsencialesPrecios de MedicamentosPolíticas de SaludAccessibility and availability of drugs has been a matter of great concern for health services all over the world, especially for less developed countries. The World Health Organization has devoted considerable time to this matter. Although the essential drug policy has been well-accepted by health agencies and NGOs, the pharmaceutical industry has not proven willing to produce essential drugs at affordable prices. The purpose of this study is to examine price levels of essential drugs in Mexico. The evaluation was performed through a comparison of international and national prices for leading drugs in the respective therapeutic categories and included in the WHO model list of essential drugs. The study shows clearly that prices of essential brand-name drugs in Mexico are very high. Per capita consumption has remained stable despite a sharp decrease in the Mexican GDP since 1995. The article discusses the reasons for this and proposes measures to deal with the problem.Para la Organización Mundial de la Salud (OMS) la accesibilidad y la disponibilidad de los medicamentos es un tema central al cual le ha dedicado una gran atención. Si bien la política de medicamentos esenciales ha tenido una acogida favorable por parte de las organizaciones sanitarias, la industria farmacéutica, especialmente sus filiales asentadas en los países menos desarrollados, no ha brindado una respuesta adecuada a los planteamientos de la OMS de proporcionar medicamentos esenciales a precios accesibles. El objetivo de este trabajo es estudiar el precio de los medicamentos esenciales de marca en México en relación al precio de los medicamentos esenciales genéricos disponibles en el mercado internacional. Se estudió una muestra de especialidades farmacéuticas líderes de ventas en su categoría terapéutica y se compararon los precios, por unidades farmacéuticas, de los medicamentos de marca y los medicamentos genéricos a precio internacional. Los resultados muestran que el nivel de precios de los medicamentos esenciales en México es muy elevado. La venta per cápita no se ha reducido, a pesar de la caída del producto interno bruto que se produjo en México a partir del año de 1995. Se discuten las razones de este sobreprecio y se proponen algunas medidas para solucionar este problema.Reports in Public HealthCadernos de Saúde Pública1998-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996Reports in Public Health; Vol. 14 No. 3 (1998): July/SeptemberCadernos de Saúde Pública; v. 14 n. 3 (1998): Julho/Setembro1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZspahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996/1982https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996/1983Molina-Salazar, Raúl E.Rivas-Vilchis, José F.info:eu-repo/semantics/openAccess2024-03-06T15:26:10Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/996Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:01:12.907392Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
title Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
spellingShingle Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
Molina-Salazar, Raúl E.
Medicamentos Esenciales
Precios de Medicamentos
Políticas de Salud
title_short Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
title_full Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
title_fullStr Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
title_full_unstemmed Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
title_sort Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México
author Molina-Salazar, Raúl E.
author_facet Molina-Salazar, Raúl E.
Rivas-Vilchis, José F.
author_role author
author2 Rivas-Vilchis, José F.
author2_role author
dc.contributor.author.fl_str_mv Molina-Salazar, Raúl E.
Rivas-Vilchis, José F.
dc.subject.por.fl_str_mv Medicamentos Esenciales
Precios de Medicamentos
Políticas de Salud
topic Medicamentos Esenciales
Precios de Medicamentos
Políticas de Salud
description Accessibility and availability of drugs has been a matter of great concern for health services all over the world, especially for less developed countries. The World Health Organization has devoted considerable time to this matter. Although the essential drug policy has been well-accepted by health agencies and NGOs, the pharmaceutical industry has not proven willing to produce essential drugs at affordable prices. The purpose of this study is to examine price levels of essential drugs in Mexico. The evaluation was performed through a comparison of international and national prices for leading drugs in the respective therapeutic categories and included in the WHO model list of essential drugs. The study shows clearly that prices of essential brand-name drugs in Mexico are very high. Per capita consumption has remained stable despite a sharp decrease in the Mexican GDP since 1995. The article discusses the reasons for this and proposes measures to deal with the problem.
publishDate 1998
dc.date.none.fl_str_mv 1998-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996
dc.language.iso.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996/1982
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/996/1983
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 14 No. 3 (1998): July/September
Cadernos de Saúde Pública; v. 14 n. 3 (1998): Julho/Setembro
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943344904110080

Registros relacionados